Article
Biosynthesis of cannabinoid precursor olivetolic acid by overcoming rate-limiting steps in genetically engineered <i>Yarrowia lipolytica</i>
2021-06-10
Abstract excerpt
Natural products acting on our central nervous systems are in utmost demand to fight against pain and mental disorders. Cannabinoids (CBDs) are proven neuroactive agents to treat anxiety, depression, chronic pain diseases, seizure, strokes and neurological disorders. The scarcity of the hemp-sourced CBD products and the prohibitive manufacturing cost limit the wide application of CBDs. Yeast metabolic engineering...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- fd06f338-d763-592d-9707-ce3647034a8d
- DOI
- 10.1101/2021.06.10.447928
